 xxxd3302xxx : a serotonin  xxxg1117xxx  receptor agonist for treatment of constipation-predominant irritable bowel syndrome.  activation of serotonin 5-ht(4) receptors has been proposed as treatment for irritable bowel syndrome, a common, complex and distressing gastrointestinal disorder. abnormal intestinal motility and sensitivity in irritable bowel syndrome patients can result in diarrhea, constipation, abdominal pain, bloating, headache and fatigue; these and other symptoms can lead to exacerbation of psychological stress, which may in turn induce further physiological abnormalities and patient discomfort. the serotonin agonist  xxxd3302xxx  binds with high affinity to 5-ht(4) receptors and has demonstrated potent pharmacological effects on the mid- and distal gut.  xxxd3302xxx  has been safely employed in clinical trials where it has demonstrated efficacy in normalizing intestinal function, thereby improving irritable bowel syndrome symptoms.